HR positive, HER2 negative breast cancer

Details

Project Status:
In Progress
Therapeutic Area:
HR positive, HER2 negative breast cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0053-000

Review Type: Rapid

Provisional Funding Algorithm

Draft Report Posted (Target): 31-Oct-2024
Stakeholder Feedback Deadline (Target): 7-Nov-2024
Final Report Posted (Target): 12-Dec-2024